Results 111 to 120 of about 192,433 (311)

Patient experiences with a smartwatch 1L-ECG versus traditional Holter monitoring for ambulatory cardiac rhythm monitoring: a qualitative study

BMJ Open
Objective To explore patients’ experiences and perspectives on using a direct-to-consumer smartwatch with single-lead electrocardiography (1L-ECG) for ambulatory rhythm diagnostics in primary care.Design Qualitative study using semi-structured interviews
Eric Wierda, Jelle C L Himmelreich, Ralf Harskamp, Eric P Moll van Charante, Evert P M Karregat, Pieter Vooijs, Wim Lucassen   +6 more
doaj   +1 more source

Ambulatory Blood Pressure Monitoring in the Elderly

International Journal of Hypertension, 2012
The incidence of hypertension is high in the elderly and is present in 2/3 of the patients older than 65 years. Prevalence can reach 90% in patients older than 80 years.
Juan Diego Mediavilla García, Fernando Jaén Águila, Celia Fernández Torres, Blas Gil Extremera, Juan Jiménez Alonso   +4 more
doaj   +1 more source

Developing a Business Case for the Care Coordination and Transition Management Model: Need, Metrics, and Measures [PDF]

, 2019
In this descriptive qualitative study, nurse and healthcare leaders\u27 experiences, perceptions of care coordination and transition management (CCTM®), and insights as to how to foster adoption of the CCTM RN role in nursing education, practice across ...
Brown, PhD, RN, CPHQ, FNAHQ, FAAN, Diane Storer, Conway-Phillips, PhD, RN, Regina, De La Pena, MSN, RNC, C-EFM, Laura, Haas, PhD, RN, FAAN, Sheila, Start, MSN, RN, NE-BC, Rachel, Swan, PhD, CRNP, FAAN, Beth Ann   +5 more
core   +1 more source

Intravenous lanadelumab for the treatment of moderately ill COVID‐19 patients

British Journal of Clinical Pharmacology, EarlyView.
Aims Kallikrein‐kinin system (KKS) dysregulation is hypothesized to play a pathogenetic role in COVID‐19‐associated pulmonary oedema. To investigate the efficacy and safety of intravenous lanadelumab, a monoclonal antibody that inhibits plasma kallikrein, in COVID‐19, we conducted a phase 2, open‐label, randomized‐controlled, proof‐of‐concept ...
Job J. Engel, Christine van Linge, W. Joost Wiersinga, Ilse J. E. Kouijzer, Quirijn de Mast, Robert‐Jan Hassing, Danique J. H. Huijbens, Helen L. Leavis, Roger Schutgens, Coen Maas, Kit C. B. Roes, Frank L. van de Veerdonk, Roger Brüggemann   +12 more
wiley   +1 more source

Adverse Events of Mood Monitoring and Ambulatory Assessment in Depression and Bipolar Disorder: Systematic Review and Meta-Analysis

JMIR Mental Health
BackgroundMood monitoring and ambulatory assessment offer improvements in measuring mood and behavior for mental health research and clinical practice.
Laurence Astill Wright, Jonathan Monk-Cunliffe, Boliang Guo, Richard Morriss   +3 more
doaj   +1 more source

Short-term reproducibility of the 24-h ambulatory monitoring of brachial and central hemodynamics in untreated Chinese

Blood Pressure, 2019
Objective: Advanced technology allows non-invasive monitoring of the 24-h brachial and central hemodynamics simultaneously. However, related reproducibility data was limited in White patients.
Ying Wang, Dong-Yan Zhang, Qian-Hui Guo, Yi-Bang Cheng, Qi-Fang Huang, Chang-Sheng Sheng, Ting-Yan Xu, Ji-Guang Wang, Yan Li   +8 more
doaj   +1 more source

Impact of secured prescription implementation on ambulatory pregabalin use in France: A regional assessment in the French Nouvelle‐Aquitaine

British Journal of Clinical Pharmacology, EarlyView.
Abstract Aim The French authorities mandated the use of secure prescriptions for pregabalin on May 2021. This study aimed to evaluate the impact of this measure on pregabalin use and misuse in Nouvelle‐Aquitaine, a southwestern French region with around six million inhabitants.
Maika Munech‐Herran, Véronique Moysan, Bruno Lescarret, Clément Mathieu, Antoine Pariente, Nicolas Rousselot   +5 more
wiley   +1 more source

Self-monitoring of blood pressure in hypertension: A systematic review and individual patient data meta-analysis.

PLoS Medicine, 2017
BackgroundSelf-monitoring of blood pressure (BP) appears to reduce BP in hypertension but important questions remain regarding effective implementation and which groups may benefit most.
Katherine L Tucker, James P Sheppard, Richard Stevens, Hayden B Bosworth, Alfred Bove, Emma P Bray, Kenneth Earle, Johnson George, Marshall Godwin, Beverly B Green, Paul Hebert, F D Richard Hobbs, Ilkka Kantola, Sally M Kerry, Alfonso Leiva, David J Magid, Jonathan Mant, Karen L Margolis, Brian McKinstry, Mary Ann McLaughlin, Stefano Omboni, Olugbenga Ogedegbe, Gianfranco Parati, Nashat Qamar, Bahman P Tabaei, Juha Varis, Willem J Verberk, Bonnie J Wakefield, Richard J McManus   +28 more
doaj   +1 more source

Organizing the U.S. Health Care Delivery System for High Performance [PDF]

, 2008
Analyzes the fragmentation of the healthcare delivery system and makes policy recommendations -- including payment reform, regulatory changes, and infrastructure -- for creating mechanisms to coordinate care across providers and ...
Anne K. Gauthier, Anthony Shih, Douglas McCarthy, Karen Davis, Rachel Nuzum, Stephen C. Schoenbaum   +5 more
core  

The evolving therapeutic landscape of spinal muscular atrophy – A scoping review of investigational agents, emerging delivery technologies and strategic innovations

British Journal of Clinical Pharmacology, EarlyView.
Spinal muscular atrophy (SMA) is a severe neuromuscular disease with emerging therapeutic complexity. This review aims to systematically map the global pipeline of investigational treatments for SMA. Using ClinicalTrials.gov and complementary international registries, we identified 21 planned or ongoing interventional trials from 2020 to 2025 targeting
Andrej Belančić, Patrick Eustaquio, Elvira Meni Maria Gkrinia, Ivana Stević, Eugen Javor, Yun Wah Lam, Slobodan Janković, Dinko Vitezić   +7 more
wiley   +1 more source